WT1 Cancer Vaccine is an innovative cancer immunotherapy focused on activating the body’s immune system to recognize and attack cancer cells. The vaccine uses the WT1 (Wilm’s Tumor 1) protein antigen, which effectively enhances immune response against various types of tumors, making it suitable for high-risk cancer patients and those in cancer recovery.
In today’s busy lives, many people may experience increased fatigue, difficulty concentrating, or slower recovery.
NAD+ intravenous infusion is a cellular energy support method that has gained increasing attention in recent years. By supplementing NAD+ intravenously, it helps the body maintain energy circulation and repair mechanisms at the cellular level.
NAD+ (nicotinamide adenine dinucleotide) is one of the important coenzymes in human cells, participating in energy conversion, DNA repair, and cellular metabolic regulation.
As we age or experience accumulated life stress, the body’s NAD+ levels may gradually decline. Therefore, appropriate supplementation and professional evaluation can be part of health management to support the body in maintaining optimal function.
During the recovery phase after treatment, some people may notice that their heartbeat feels more noticeable than before.
For example, while sitting quietly they may become aware of their heartbeat in the chest, or after mild activities such as walking or climbing stairs, the heartbeat may feel more pronounced.
Some individuals even describe it as being able to clearly feel their heartbeat, yet medical examinations often do not reveal any obvious abnormalities.
This situation is not uncommon during the recovery period and is usually related to the body’s gradual process of adjustment and recovery.
During or after treatment, some individuals notice that their skin becomes drier than before. It may also feel itchy, slightly flaky, or more sensitive.
Some people find that skincare products they used comfortably in the past suddenly feel unsuitable, or that their skin reacts more strongly to weather changes.
These changes are not uncommon during the recovery phase and are often related to temporary adjustments in the skin’s barrier function.
During or after treatment, some individuals notice that foods they once enjoyed no longer taste the same. Flavors may seem bland, bitter, or even metallic.
Some people do not lack the desire to eat, but rather feel unable to tolerate food, or find that eating has become uncomfortable.
This change is often underestimated, yet it can have a significant impact during the recovery phase.
During or after treatment, some individuals notice numbness or tingling in their fingers or toes, sometimes described as a pins-and-needles sensation.
Others may find that handling objects becomes less precise, or that the soles of their feet feel dull while walking.
This situation is not uncommon in clinical settings and is typically related to changes in peripheral nerve function.
After completing treatment, some individuals notice that they become short of breath after walking only a short distance, their heart rate feels faster than before, or they occasionally experience dizziness.
These changes are often mistaken for simple lack of rest. However, the underlying causes may involve more specific physiological factors.
In discussions about cancer-related nutrition and supportive therapies, “antioxidants” are frequently mentioned. Among them, glutathione is one of the body’s most important endogenous antioxidants.
Many patients hear about glutathione during treatment, yet fewer fully understand how it functions in the body and when supplementation may or may not be appropriate.
Vitamin D is one of the most frequently discussed nutrients in cancer-related nutrition.
Beyond its well-known role in bone health, vitamin D is also involved in immune regulation, cellular differentiation, and inflammatory balance. For this reason, many patients undergoing treatment or in recovery begin to wonder:
Am I deficient in vitamin D? Should I be supplementing?
Among supportive therapies discussed in the context of cancer care, high-dose vitamin C intravenous (IV) therapy remains one of the most debated options.
Some believe it may help improve fatigue or overall vitality, while others question whether it could interfere with primary treatments. In a landscape filled with mixed information, the key is not to take sides—but to understand its biological rationale and appropriate clinical context.